Litcius/Paper detail

Average daily glucocorticoid dose, number of prescription days, and cumulative dose in the initial 90 days of glucocorticoid therapy are associated with subsequent hip and clinical vertebral fracture risk: a retrospective cohort study using a nationwide health insurance claims database in Japan

Masayuki Iki, Kenji Fujimori, Shinichi Nakatoh, Junko Tamaki, Shigeyuki Ishii, Nobukazu Okimoto, Hironori Imano, Sumito Ogawa

2024Osteoporosis International13 citationsDOI

Topics & Concepts

MedicineHip fractureInternal medicinePrednisoloneConfoundingGlucocorticoidRetrospective cohort studyCohort studyRheumatologyCohortCumulative doseSurgeryOsteoporosisBone health and osteoporosis researchBone and Joint DiseasesAdrenal Hormones and Disorders
Average daily glucocorticoid dose, number of prescription days, and cumulative dose in the initial 90 days of glucocorticoid therapy are associated with subsequent hip and clinical vertebral fracture risk: a retrospective cohort study using a nationwide health insurance claims database in Japan | Litcius